|
Volumn 7, Issue 4, 2001, Pages 1026-1032
|
Angiogenesis inhibitor TNP-470 during bone marrow transplant: Safety in a preclinical model
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
FUMAGILLOL CHLOROACETYLCARBAMATE;
PLACEBO;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BOLUS INJECTION;
BONE MARROW TRANSPLANTATION;
CANCER RECURRENCE;
CELL MATURATION;
COLONY FORMING CELL;
CONTINUOUS INFUSION;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG SAFETY;
FEASIBILITY STUDY;
GRAFT SURVIVAL;
HEMATOPOIESIS;
HUMAN;
HUMAN CELL;
LYMPHOID CELL;
MORTALITY;
MOUSE;
NEUROBLASTOMA;
NONHUMAN;
PRIORITY JOURNAL;
SOLID TUMOR;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
ANGIOGENESIS INHIBITORS;
ANIMALS;
BONE MARROW;
BONE MARROW TRANSPLANTATION;
COLONY-FORMING UNITS ASSAY;
CYCLOHEXANES;
DISEASE MODELS, ANIMAL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MICE;
MICE, TRANSGENIC;
MORTALITY;
REPRODUCIBILITY OF RESULTS;
SESQUITERPENES;
|
EID: 0034900497
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (7)
|
References (25)
|